The largest database of trusted experimental protocols

Millennium 120 multileaf collimator

Manufactured by Agilent Technologies
Sourced in United States

The Millennium 120 multileaf collimator is a device used in radiotherapy treatments. It is designed to precisely shape and control the radiation beam delivered to the patient during treatment. The collimator consists of multiple individually-controlled leaves that can be positioned to conform the radiation field to the specific shape of the target area.

Automatically generated - may contain errors

5 protocols using millennium 120 multileaf collimator

1

Acuros XB Dose Calculation Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The same set of beam data used by AAA version 11 measured by two IBA CC13 ion chambers (IBA, Barlett, TN) in a 3D Blue Phantom (Wellhöfer, IBA Dosimetry America, Barlett, TN, USA) for field sizes 2 × 2–40 × 40 cm2 were imported for the configuration of Acuros XB 11. All data used in this study were taken for 6 & 23 MV photon beams generated from a Varian Clinac iX accelerators equipped with a Millennium 120 multileaf collimator (Varian Medical Systems, Palo Alto, CA, USA). After commissioning the Acuros XB, measurements of the point dose were performed for field sizes ranging from 6 × 6 to 40 × 40 cm2 on the same water tank and the measurements were compared with dose calculated by AAA and Acuros.
The dose calculation grid resolution can be set by users from 1 to 5 mm for AAA and 1 to 3 mm for Acuros XB during the treatment planning. In this study, the dose grid size was set at 2.5 mm which is typically used in our clinics.
+ Open protocol
+ Expand
2

Lung Tumor Irradiation Protocol with Varied Beam Types

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tumor was irradiated by seven coplanar beams collimated to the tumor with a Millennium 120 multileaf collimator (Varian Medical Systems). The leaves were positioned so as to create a 5-mm gap around the tumor. The isocenter for all beams was at the tumor center, and the source-to-axis distance was 1 m. For the FF beams, the beam energy was set at 6 MV because this is the most common energy used for treating lung tumors. For FFF beams, we also chose 6 MV because two recent studies have shown better sparing of organs at risk with 6 MV FFF beams than with 10 MV FFF beams (Lu et al. 2015 (link); Tambe et al. 2016 ). All dose distributions were normalized to deliver 50 Gy (prescription dose, Dx) to the isocenter. We used this point normalization, rather than a planning target volume (PTV) coverage-based normalization, to remove the impact of dose calculation uncertainties in the transition region between the tumor and the lung, as that region was the focus of our study. The impact of electronic disequilibrium at the edge of the tumor was evaluated by comparing the dose calculated in the phantom as described above (for each lung density and tumor volume) versus the dose calculated in the phantom where the lung tissue was replaced with water.
+ Open protocol
+ Expand
3

Beam data analysis for AXB configuration

Check if the same lab product or an alternative is used in the 5 most similar protocols
The same set of beam data (including percentage depth dose curve, profiles and output factors) used by AAA and measured in a three-dimensional water scanning system (PTW, Germany) for field sizes from 3 × 3 to 40 × 40 cm2 were imported in Eclipse treatment planning system (Version 10.0, Varian Medical Systems, Palo Alto, CA) for the configuration of AXB. All data presented in this study were collected from a commissioned Varian Truebeam™ accelerator equipped with a Millennium 120 multileaf collimator (MLC, with spatial resolution of 5 and 10 mm for the central and outer 20 cm, respectively.
+ Open protocol
+ Expand
4

Hypofractionated VMAT for Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten prostate cancer patients treated with hypofractionated VMAT (67.6 Gy/26 Fr) in our hospital were studied. All plans contained one or two full arcs. Each plan was generated in Eclipse treatment planning system version 8.6 (Varian Medical Systems, Palo Alto, CA). All prostate plans were planned for a 15 MV X‐ray beam on Varian 23 EX with a millennium 120 multileaf collimator. Average X jaw size with a standard deviation was 8.84±0.59cm. Average Y jaw size with a standard deviation was 8.90±0.83cm. The dose calculation algorithm was anisotropic analytical algorithm (AAA) version 11.0.1. The calculation grid size was 1×1×1mm3.
+ Open protocol
+ Expand
5

Photon Beam Quality Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
On the Eclipse treatment planning system V13.5, the aforementioned RapidPlan model was applied to estimate the best achievable DVHs under five photon beam qualities from a Varian TrueBeam accelerator equipped with Millennium 120 multi-leaf collimator (MLC), including 6-MV flattened (6X), 6-MV flattening-filter-free mode (6F), 8X, 10X and 10F respectively, for 20 historical patients that were not included in the model library. Higher energies are not used at our center for the consideration of secondary neutron contamination [19 ], hence were not tested in this study. Without any human intervention, VMAT plans were optimized using the RapidPlan-generated patient-specific objectives [20 ], keeping the original beam geometries of the clinical plans unchanged. The prescription dose was 41.8Gy for PTV and 50.6Gy for PTVboost. The volume dose was calculated using analytical anisotropic algorithm (AAA). All plans were normalized to cover 95% target volume with 100% prescription dose before comparison.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!